Mitosol 0.2 MG kits
Ended Awarded
- Contract number
- SPE2DX25F6XSR
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $3,947
Award facts
- Contract value 100% obligated
- $3,947.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,947.40 on September 9, 2025, for the supply of Mitosol 0.2 mg kits. The contract, which carries no set-aside designation, is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) under the SPE2DB program, valued at $499.999 billion and extending through November 2026. This delivery order falls within the broader framework of that IDC, which enables the federal government to procure a comprehensive range of pharmaceutical products, branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide.
The contract is funded by the Medical Supply Chain, a defense-focused federal agency, with performance to be completed by September 30, 2025, at the contractor's facility in Park Ridge, Illinois. Mitosol (mitomycin) is an anti-cancer medication used in ophthalmologic and other medical procedures, reflecting DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain. The company's consistent success in securing federal contracts demonstrates its capacity to efficiently deliver specialized pharmaceutical products to military and federal healthcare systems across the nation.
Quick answers
Who was awarded contract SPE2DX25F6XSR?
SPE2DX25F6XSR was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 9, 2025.
How much is contract SPE2DX25F6XSR worth?
The government has obligated $3,947 on SPE2DX25F6XSR.
Is contract SPE2DX25F6XSR an order under another contract?
Yes. SPE2DX25F6XSR is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XSR competed?
The extent of competition for SPE2DX25F6XSR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award